BANK OF AMERICA CORP /DE/

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$439,256	385,312	+2	+0%	$1.14	Q4 2025
30 Sep 2025	0%	0%	$489,343	385,310	-201	-0.05%	$1.27	Q3 2025
30 Jun 2025	0%	0%	$408,642	385,511	+28	+0.01%	$1.06	Q2 2025
31 Mar 2025	0%	0%	$524,257	385,483	+8		$1.36	Q1 2025
31 Dec 2024	0%	+0%	$531,956	385,475	+369,265	+2278%	$1.38	Q4 2024
30 Sep 2024	0%	0%	$17,344	16,210	+574	+3.7%	$1.07	Q3 2024
30 Jun 2024	0%	0%	$33,617	15,636	+664	+4.4%	$2.15	Q2 2024
31 Mar 2024	0%	-0%	$48,660	14,972	-6,922	-32%	$3.25	Q1 2024
31 Dec 2023	0%	+0%	$448,608	21,894	+18,799	+607%	$20.49	Q4 2023
30 Sep 2023	0%	-0%	$49,768	3,095	-9,121	-75%	$16.08	Q3 2023
30 Jun 2023	0%	-0%	$103,836	12,216	-13,700	-53%	$8.50	Q2 2023
31 Mar 2023	0%	+0%	$255,791	25,916	+1,202	+4.9%	$9.87	Q1 2023
31 Dec 2022	0%	+0%	$235,525	24,714	+11,548	+88%	$9.53	Q4 2022
30 Sep 2022	0%	+0%	$229,000	13,166	+11,527	+703%	$17.39	Q3 2022
30 Jun 2022	0%	+0%	$13,000	1,639	+1,639	NEW	$7.93	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.